Heart Health After Cardiac Treatment: tailored cardiac rehabilitation in a safety‑net hospital.
The Heart Health After Cardiac Treatment Study
This program will test whether offering a tailored cardiac rehabilitation program at a safety‑net hospital helps more patients who had heart attacks, heart procedures, or heart failure attend rehab than a usual referral to an outside program.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 1 site (San Francisco, California) |
| Trial ID | NCT07158515 on ClinicalTrials.gov |
What this trial studies
Adults referred for cardiac rehabilitation are assigned to either a tailored in‑house cardiac rehabilitation program delivered at a safety‑net hospital or to usual‑care referral to an external cardiac rehabilitation program. The in‑house program provides language support in English, Spanish, and Cantonese to improve access for diverse patients. The main outcome is participation in cardiac rehabilitation, measured by attendance and completion among patients with indications such as myocardial infarction, PCI, CABG, valve surgery, transplant, chronic angina, or systolic heart failure (EF ≤35%). Patients in hospice or those whose providers do not permit approach are excluded, and prospective consent is required.
Who should consider this trial
Good fit: Adults 18 and older referred for cardiac rehabilitation for covered indications (acute MI, PCI, CABG, valve repair/replacement, heart transplant, chronic angina, or chronic systolic heart failure with EF ≤35%) who can consent and communicate in English, Spanish, or Cantonese are ideal candidates.
Not a fit: Patients currently enrolled in hospice, those whose providers decline study approach, people unable to consent, those who cannot attend care at the San Francisco site, or who do not speak the supported languages are unlikely to benefit from participation.
Why it matters
Potential benefit: If successful, this approach could substantially increase cardiac rehabilitation participation among underserved patients, leading to better recovery and fewer future heart problems.
How similar studies have performed: Previous research indicates that tailored and home‑based cardiac rehabilitation can improve participation, but relatively few comparative interventions have been conducted specifically within safety‑net hospital settings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18+ 2. Referred for cardiac rehabilitation for a covered indication: 1. Acute myocardial infarction 2. Percutaneous coronary intervention 3. Coronary artery bypass surgery 4. Heart valve repair or replacement 5. Heart transplant 6. Chronic stable angina 7. Chronic systolic heart failure (EF \<=35%) 3. Able to communicate in English, Spanish, or Cantonese 4. Able to consent for self Exclusion Criteria: 1. Currently enrolled in hospice. 2. Provider says patient may not be approached for participation in this study.
Where this trial is running
San Francisco, California
- Zuckerberg San Francisco General Hospital — San Francisco, California, United States (Recruiting)
Study contacts
- Principal investigator: Alexis Beatty, MD, MAS — University of California, San Francisco
- Study coordinator: Alisa Boyd, MPH
- Email: heartact@ucsf.edu
- Phone: 415-514-7905
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.